Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

Recent & Breaking News (TSXV:CZO)

Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting

GlobeNewswire June 13, 2018

Ceapro Announces Results of 2018 Shareholders’ Meeting

GlobeNewswire June 5, 2018

Ceapro Inc. Confirms Excellent Bioavailability of its New Water Soluble Chemical Complex Coenzyme Q10-Beta Glucan

GlobeNewswire May 29, 2018

Ceapro Inc. to Provide a Corporate Update at Its Annual General and Special Meeting of Shareholders on May 29, 2018

GlobeNewswire May 24, 2018

Ceapro Inc. Reports 2018 First Quarter Results

GlobeNewswire May 17, 2018

Ceapro Inc. Reports 2017 Financial Results

GlobeNewswire April 20, 2018

Ceapro Inc. Announces Important Collaboration with Prestigious Montreal Heart Institute

GlobeNewswire April 18, 2018

Ceapro Inc. to Present at the 12th International Symposium on Supercritical Fluids

GlobeNewswire April 13, 2018

Ceapro Announces Acceptance of Abstract for Presentation at the Nutrition 2018 Meeting

GlobeNewswire April 3, 2018

Ceapro to Present at the Wall Street Investor Forum

GlobeNewswire March 15, 2018

Ceapro Inc. to Consider Judgements in AVAC Ltd. Actions

MarketWire Canada January 29, 2018

Ceapro to Present at Noble Capital Markets' 14th Annual Investor Conference

MarketWire Canada January 17, 2018

Ceapro Announces Grant of Stock Options and Restricted Share Units

Marketwired January 2, 2018

Ceapro Reports 2017 Third Quarter Business Update and Financial Results

MarketWire Canada November 15, 2017

Ceapro Inc. Announces the Launch of its Proprietary Line of Cosmeceutical Products, JUVENTE

MarketWire Canada October 26, 2017

Ceapro Reports 2017 Second Quarter Business Update and Financial Results

MarketWire Canada August 18, 2017

Ceapro Announces Results of 2017 Shareholders' Meeting

MarketWire Canada June 5, 2017

Ceapro Inc. Announces its First Major Milestones with its PGX Enabling Technology

MarketWire Canada June 1, 2017

Ceapro Inc. to Provide a Corporate Update to Shareholders on June 1, 2017

MarketWire Canada May 26, 2017

Ceapro Inc. Reports 2017 First Quarter Development Highlights and Financial Results

MarketWire Canada May 17, 2017